Functional Constipation (FC)
Gastroenterology
Prevalence
11200.0 / 100K
Incidence
400.0 / 100K/yr
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| LINZESS | IRONWOOD PHARMACEUTICALS INC (IRWD) |
Phase 3(1)
| Drug | Company |
|---|---|
| Linaclotide | AbbVie Inc. (ABBV) |
Compare drugs
Frequently asked questions
How many drugs are in development for Functional Constipation (FC)?
BioSniper tracks 2 drugs in development for Functional Constipation (FC) across 2 companies.
How many clinical trials target Functional Constipation (FC)?
There are 1 clinical trial targeting Functional Constipation (FC) tracked by BioSniper.
What is the prevalence of Functional Constipation (FC)?
The estimated prevalence of Functional Constipation (FC) is approximately 11200.0 per 100,000 population.
Deep-dive into Functional Constipation (FC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis